1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumption for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Government Focus on Immunization Programs
4.2.2. Technological Advancements in Vaccine Administration
4.2.3. Use of Inactivated Vaccines in Surgeries or Treatment
4.3. Restraints
4.3.1. High Costs Involved in Vaccine Development
4.3.2. Long Timelines of Vaccine Manufacturing
4.4. Opportunities
4.4.1. Growing Focus on Therapeutic Vaccines
4.4.2. Increasing Use of Adjuvants in Vaccines
4.4.3. Growth Prospects in Emerging Markets
4.4.4. Development of Highly Stable and Energy-efficient Ultra-low Temperature Freezers
4.5. Challenges
4.5.1. Product Recalls
4.5.2. Inadequate Access to Vaccines
4.6. Technology Trends/Market Trends
4.6.1. Increasing Preference for Personalized Treatments
4.6.2. Media and Public Awareness Regarding Immunization
4.7. Regulatory Scenario
4.8. Pricing Analysis
4.9. Parent Market Analysis
4.10. Porter’s Five Forces Analysis
5. Viral Vaccines Market—by Form
5.1. Overview
5.2. Liquid Vaccines
5.3. Lyophilized Vaccines
6. Viral Vaccines Market—by Vaccine Type
6.1. Overview
6.2. Subunit & Conjugate Vaccines
6.3. Live-attenuated Vaccines
6.4. Inactivated Vaccines
6.5. mRNA Vaccines
6.6. Viral Vector Vaccines
6.7. Toxoid Vaccines
6.8. Combination Vaccines
7. Viral Vaccines Market—by Virus Type
7.1. Overview
7.2. Adenovirus
7.3. Retrovirus
7.4. Plasmid DNA
7.5. Adeno-associated Virus (AAV)
7.6. Lentivirus
7.7. Other Virus Types
8. Viral Vaccines Market—by Route of Administration
8.1. Overview
8.2. Intramuscular (IM)
8.3. Subcutaneous (SC)
8.4. Oral
8.5. Other Routes of Administration
9. Viral Vaccines Market—by Approach
9.1. Overview
9.2. Preventive
9.3. Therapeutic
10. Viral Vaccines Market—by Indication
10.1. Overview
10.2. Cancer
10.3. Genetic Disorders
10.4. Infectious Diseases
10.5. Other Indications
11. Viral Vaccines Market—by Application
11.1. Overview
11.2. Antisense Therapy
11.3. Gene Therapy
11.4. Cell Therapy
11.5. Vaccinology
12. Viral Vaccines Market—by Packaging
12.1. Vials
12.2. Prefilled Syringes
13. Viral Vaccines Market—by Geography
13.1. Overview
13.2. North America
13.2.1. U.S.
13.2.2. Canada
13.3. Europe
13.3.1. Germany
13.3.2. France
13.3.3. U.K.
13.3.4. Italy
13.3.5. Spain
13.3.6. Switzerland
13.3.7. Ireland
13.3.8. Denmark
13.3.9. Belgium
13.3.10. Rest of Europe
13.4. Asia-Pacific
13.4.1. Japan
13.4.2. China
13.4.3. India
13.4.4. South Korea
13.4.5. Rest of Asia Pacific
13.5. Latin America
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Middle East & Africa
14. Competitive Analysis
14.1. Overview
14.2. Key Growth Strategies
14.3. Competitive Benchmarking
14.4. Competitive Dashboard
14.4.1. Market Leaders
14.4.2. Market Differentiators
14.4.3. Vanguards
14.4.4. Emerging Companies
14.5. Market Share Analysis/ Market Ranking, by Key Players (2023)
15. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
15.1. Pfizer, Inc.
15.2. AstraZeneca plc
15.3. GlaxoSmithKline plc
15.4. Sanofi S.A.
15.5. CSL Ltd.
15.6. Mitsubishi Tanabe Pharma Corporation
15.7. Merck & Co., Inc.
15.8. Moderna, Inc.
15.9. Johnson & Johnson Services, Inc.
15.10. Dynavax Technologies Corporation
15.11. Serum Institute of India Pvt. Ltd
15.12. Emergent BioSolutions, Inc.
15.13. Bharat Biotech International Limited (BBIL)
15.14. Valneva SE
(Note: SWOT analysis will be provided for the top 5 players only)
16. Appendix
16.1. Available Customization
16.2. Related Reports
List of Tables
Table 1 Global Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 2 Global Liquid Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Lyophilized Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 5 Global Subunit & Conjugate Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Live-attenuated Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Inactivated Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global mRNA Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Viral Vector Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Toxoid Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Combination Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 13 Global Adenovirus Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Retrovirus Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Plasmid DNA Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Adeno-associated Virus (AAV) Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Lentivirus Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Viral Vaccines Market for Other Virus Types, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 20 Global Intramuscular (IM) Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Subcutaneous (SC) Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Oral Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Viral Vaccines Market for Other Routes of Administration, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 25 Global Preventive Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 26 Global Therapeutic Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 27 Global Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 28 Global Viral Vaccines Market for Infectious Diseases, by Country/Region, 2022–2031 (USD Million)
Table 29 Global Viral Vaccines Market for Cancer, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Viral Vaccines Market for Genetic Disorders, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Viral Vaccines Market for Other Indications, by Country/Region, 2022–2031 (USD Million)
Table 32 Global Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 33 Global Viral Vaccines Market for Antisense Therapy, by Country/Region, 2022–2031 (USD Million)
Table 34 Global Viral Vaccines Market for Gene Therapy, by Country/Region, 2022–2031 (USD Million)
Table 35 Global Viral Vaccines Market for Cell Therapy, by Country/Region, 2022–2031 (USD Million)
Table 36 Global Viral Vaccines Market for Vaccinology, by Country/Region, 2022–2031 (USD Million)
Table 37 Global Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 38 Global Viral Vaccine Vials Market, by Country/Region, 2022–2031 (USD Million)
Table 39 Global Prefilled Viral Vaccine Syringes Market, by Country/Region, 2022–2031 (USD Million)
Table 40 Global Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 41 North America: Viral Vaccines Market, by Country, 2022–2031 (USD Million)
Table 42 North America: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 43 North America: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 44 North America: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 45 North America: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 46 North America: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 47 North America: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 48 North America: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 49 North America: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 50 U.S.: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 51 U.S.: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 52 U.S.: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 53 U.S.: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 54 U.S.: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 55 U.S.: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 56 U.S.: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 57 U.S.: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 58 Canada: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 59 Canada: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 60 Canada: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 61 Canada: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 62 Canada: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 63 Canada: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 64 Canada: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 65 Canada: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 66 Europe: Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 67 Europe: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 68 Europe: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 69 Europe: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 70 Europe: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 71 Europe: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 72 Europe: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 73 Europe: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 74 Europe: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 75 Germany: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 76 Germany: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 77 Germany: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 78 Germany: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 79 Germany: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 80 Germany: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 81 Germany: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 82 Germany: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 83 France: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 84 France: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 85 France: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 86 France: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 87 France: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 88 France: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 89 France: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 90 France: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 91 U.K.: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 92 U.K.: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 93 U.K.: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 94 U.K.: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 95 U.K.: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 96 U.K.: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 97 U.K.: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 98 U.K.: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 99 Italy: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 100 Italy: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 101 Italy: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 102 Italy: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 103 Italy: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 104 Italy: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 105 Italy: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 106 Italy: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 107 Spain: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 108 Spain: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 109 Spain: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 110 Spain: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 111 Spain: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 112 Spain: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 113 Spain: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 114 Spain: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 115 Switzerland: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 116 Switzerland: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 117 Switzerland: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 118 Switzerland: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 119 Switzerland: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 120 Switzerland: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 121 Switzerland: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 122 Switzerland: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 123 Ireland: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 124 Ireland: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 125 Ireland: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 126 Ireland: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 127 Ireland: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 128 Ireland: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 129 Ireland: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 130 Ireland: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 131 Denmark: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 132 Denmark: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 133 Denmark: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 134 Denmark: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 135 Denmark: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 136 Denmark: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 137 Denmark: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 138 Denmark: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 139 Belgium: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 140 Belgium: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 141 Belgium: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 142 Belgium: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 143 Belgium: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 144 Belgium: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 145 Belgium: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 146 Belgium: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 147 Rest of Europe: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 148 Rest of Europe: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 149 Rest of Europe: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 150 Rest of Europe: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 151 Rest of Europe: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 152 Rest of Europe: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 153 Rest of Europe: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 154 Rest of Europe: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 155 Asia-Pacific: Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 156 Asia-Pacific: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 157 Asia-Pacific: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 158 Asia-Pacific: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 159 Asia-Pacific: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 160 Asia-Pacific: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 161 Asia-Pacific: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 162 Asia-Pacific: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 163 Asia-Pacific: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 164 China: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 165 China: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 166 China: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 167 China: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 168 China: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 169 China: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 170 China: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 171 China: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 172 Japan: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 173 Japan: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 174 Japan: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 175 Japan: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 176 Japan: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 177 Japan: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 178 Japan: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 179 Japan: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 180 India: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 181 India: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 182 India: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 183 India: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 184 India: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 185 India: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 186 India: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 187 India: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 188 South Korea: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 189 South Korea: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 190 South Korea: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 191 South Korea: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 192 South Korea: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 193 South Korea: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 194 South Korea: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 195 South Korea: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 196 Rest of Asia-Pacific: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 197 Rest of Asia-Pacific: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 198 Rest of Asia-Pacific: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 199 Rest of Asia-Pacific: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 200 Rest of Asia-Pacific: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 201 Rest of Asia-Pacific: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 202 Rest of Asia-Pacific: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 203 Rest of Asia-Pacific: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 204 Latin America: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 205 Latin America: Viral Vaccines Market, by Country/Region, 2022–2031 (USD Million)
Table 206 Latin America: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 207 Latin America: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 208 Latin America: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 209 Latin America: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 210 Latin America: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 211 Latin America: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 212 Latin America: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 213 Brazil: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 214 Brazil: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 215 Brazil: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 216 Brazil: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 217 Brazil: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 218 Brazil: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 219 Brazil: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 220 Brazil: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 221 Mexico: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 222 Mexico: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 223 Mexico: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 224 Mexico: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 225 Mexico: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 226 Mexico: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 227 Mexico: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 228 Mexico: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 229 Rest of Latin America: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 230 Rest of Latin America: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 231 Rest of Latin America: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 232 Rest of Latin America: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 233 Rest of Latin America: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 234 Rest of Latin America: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 235 Rest of Latin America: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 236 Rest of Latin America: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 237 Middle East & Africa: Viral Vaccines Market, by Form, 2022–2031 (USD Million)
Table 238 Middle East & Africa: Viral Vaccines Market, by Vaccine Type, 2022–2031 (USD Million)
Table 239 Middle East & Africa: Viral Vaccines Market, by Virus Type, 2022–2031 (USD Million)
Table 240 Middle East & Africa: Viral Vaccines Market, by Route of Administration, 2022–2031 (USD Million)
Table 241 Middle East & Africa: Viral Vaccines Market, by Approach, 2022–2031 (USD Million)
Table 242 Middle East & Africa: Viral Vaccines Market, by Indication, 2022–2031 (USD Million)
Table 243 Middle East & Africa: Viral Vaccines Market, by Application, 2022–2031 (USD Million)
Table 244 Middle East & Africa: Viral Vaccines Market, by Packaging, 2022–2031 (USD Million)
Table 245 Recent Developments, by Company, 2021–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Viral Vaccines Market, by Form, 2024 Vs. 2031 (USD Million)
Figure 8 Global Viral Vaccines Market, by Vaccine Type, 2024 Vs. 2031 (USD Million)
Figure 9 Global Viral Vaccines Market, by Virus Type, 2024 Vs. 2031 (USD Million)
Figure 10 Global Viral Vaccines Market, by Route of Administration, 2024 Vs. 2031 (USD Million)
Figure 11 Global Viral Vaccines Market, by Approach, 2024 Vs. 2031 (USD Million)
Figure 12 Global Viral Vaccines Market, by Indication, 2024 Vs. 2031 (USD Million)
Figure 13 Global Viral Vaccines Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 14 Global Viral Vaccines Market, by Packaging, 2024 Vs. 2031 (USD Million)
Figure 15 Global Viral Vaccines Market, by Geography
Figure 16 Global Viral Vaccines Market, by Form, 2024 Vs. 2031 (USD Million)
Figure 17 Global Viral Vaccines Market, by Vaccine Type, 2024 Vs. 2031 (USD Million)
Figure 18 Global Viral Vaccines Market, by Virus Type, 2024 Vs. 2031 (USD Million)
Figure 19 Global Viral Vaccines Market, by Route of Administration, 2024 Vs. 2031 (USD Million)
Figure 20 Global Viral Vaccines Market, by Approach, 2024 Vs. 2031 (USD Million)
Figure 21 Global Viral Vaccines Market, by Indication, 2024 Vs. 2031 (USD Million)
Figure 22 Global Viral Vaccines Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 23 Global Viral Vaccines Market, by Packaging, 2024 Vs. 2031 (USD Million)
Figure 24 Global Viral Vaccines Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 25 North America: Viral Vaccines Market Snapshot
Figure 26 Europe: Viral Vaccines Market Snapshot
Figure 27 Asia-Pacific: Viral Vaccines Market Snapshot
Figure 28 Latin America: Viral Vaccines Market Snapshot
Figure 29 Key Growth Strategies Adopted by Leading Players, 2021–2024
Figure 30 Global Viral Vaccines Market: Competitive Benchmarking, by Vaccine Type
Figure 31 Global Viral Vaccines Market: Competitive Dashboard
Figure 32 Global Viral Vaccines Market: Market Share Analysis/Market Ranking (2023)
Figure 33 Pfizer, Inc.: Financial Overview (2023)
Figure 34 AstraZeneca plc: Financial Overview (2023)
Figure 35 GlaxoSmithKline plc: Financial Overview (2022)
Figure 36 Sanofi S.A.: Financial Overview (2023)
Figure 37 CSL Ltd.: Financial Overview (2023)
Figure 38 Merck & Co, Inc.: Financial Overview (2023)
Figure 39 Moderna, Inc.: Financial Overview (2023)
Figure 40 Johnson & Johnson Services, Inc.: Financial Overview (2023)
Figure 41 Dynavax Technologies Corporation: Financial Overview (2023)
Figure 42 Emergent BioSolution, Inc.: Financial Overview (2023)
Figure 43 Valneva SE: Financial Overview (2023)